Nose
- 3E093 - Percutaneous
- 3E0930
- 3E09305 - Introduction Nose to Other Antineoplastic with Antineoplastic, Percutaneous Approach
- 3E0930M - Introduction Nose to Monoclonal Antibody with Antineoplastic, Percutaneous Approach
- 3E0932
- 3E09328 - Introduction Nose to Oxazolidinones with Anti-infective, Percutaneous Approach
- 3E09329 - Introduction Nose to Other Anti-infective with Anti-infective, Percutaneous Approach
- 3E0933
- 3E0933Z - Introduction Nose to No Qualifier with Anti-inflammatory, Percutaneous Approach
- 3E0934
- 3E0934Z - Introduction Nose to No Qualifier with Serum, Toxoid and Vaccine, Percutaneous Approach
- 3E093B
- 3E093BZ - Introduction Nose to No Qualifier with Anesthetic Agent, Percutaneous Approach
- 3E093G
- 3E093GC - Introduction Nose to Other Substance with Other Therapeutic Substance, Percutaneous Approach
- 3E093H
- 3E093HZ - Introduction Nose to No Qualifier with Radioactive Substance, Percutaneous Approach
- 3E093K
- 3E093KZ - Introduction Nose to No Qualifier with Other Diagnostic Substance, Percutaneous Approach
- 3E093N
- 3E093NZ - Introduction Nose to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach
- 3E093T
- 3E093TZ - Introduction Nose to No Qualifier with Destructive Agent, Percutaneous Approach
- 3E097 - Via Natural or Artificial Opening
- 3E0970
- 3E09705 - Introduction Nose to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach
- 3E0970M - Introduction Nose to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach
- 3E0972
- 3E09728 - Introduction Nose to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach
- 3E09729 - Introduction Nose to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach
- 3E0973
- 3E0973Z - Introduction Nose to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach
- 3E0974
- 3E0974Z - Introduction Nose to No Qualifier with Serum, Toxoid and Vaccine, Via Natural or Artificial Opening Approach
- 3E097B
- 3E097BZ - Introduction Nose to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach
- 3E097G
- 3E097GC - Introduction Nose to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach
- 3E097H
- 3E097HZ - Introduction Nose to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach
- 3E097K
- 3E097KZ - Introduction Nose to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach
- 3E097N
- 3E097NZ - Introduction Nose to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach
- 3E097T
- 3E097TZ - Introduction Nose to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach
- 3E09X - External
- 3E09X0
- 3E09X05 - Introduction Nose to Other Antineoplastic with Antineoplastic, External Approach
- 3E09X0M - Introduction Nose to Monoclonal Antibody with Antineoplastic, External Approach
- 3E09X2
- 3E09X28 - Introduction Nose to Oxazolidinones with Anti-infective, External Approach
- 3E09X29 - Introduction Nose to Other Anti-infective with Anti-infective, External Approach
- 3E09X3
- 3E09X3Z - Introduction Nose to No Qualifier with Anti-inflammatory, External Approach
- 3E09X4
- 3E09X4Z - Introduction Nose to No Qualifier with Serum, Toxoid and Vaccine, External Approach
- 3E09XB
- 3E09XBZ - Introduction Nose to No Qualifier with Anesthetic Agent, External Approach
- 3E09XG
- 3E09XGC - Introduction Nose to Other Substance with Other Therapeutic Substance, External Approach
- 3E09XH
- 3E09XHZ - Introduction Nose to No Qualifier with Radioactive Substance, External Approach
- 3E09XK
- 3E09XKZ - Introduction Nose to No Qualifier with Other Diagnostic Substance, External Approach
- 3E09XN
- 3E09XNZ - Introduction Nose to No Qualifier with Analgesics, Hypnotics, Sedatives, External Approach
- 3E09XT
- 3E09XTZ - Introduction Nose to No Qualifier with Destructive Agent, External Approach